Latest filing published 20 May 2019 for aTYR PHARMA INC.
Filing timeline
BuySaleInsider track record
No signal scores available.
Nancy Krueger: trading record in brief
Nancy Krueger discloses dealings in aTYR PHARMA Inc to SEC (Form 4). The record holds 2 filings, for trades running from 16 May 2019 to 17 May 2019.
No open-market purchase appears, only 1 sale worth €1,874. Besides market trades, the filings include 1 option exercise.
The latest filing, published on 20 May 2019, reports an option exercise in aTYR PHARMA Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Nancy Krueger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,500 shares0Common StockSEC:0001209191-19-031424:0
- 4,651 shares@ US$0.4501100.0% of flowCommon StockSEC:0001209191-19-031424:1
2 of 2 declarations